 CLEARWATER, Fla.--BUSINESS WIRE--Apyx Medical Corporation NASDAQ:APYX the Company, a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market, today reported financial results for its second quarter ended June 30, 2021 and updated its financial outlook for the full year ending December 31, 2021. Second Quarter 2021 Financial Summary: Total revenue of 1 